AMYLIN PHARMACEUTICALS, INC.
Patent Owner
Stats
- 32 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Aug 29, 2013 most recent publication
Details
- 32 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 4,215 Total Citation Count
- May 01, 1989 Earliest Filing
- 85 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2003/0087,820 Novel exendin agonist formulations and methods of administration thereofMay 28, 02May 08, 03[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8293871 Poly(lactide-co-glycolide) based sustained release microcapsules comprising a polypeptide and a sugarApr 15, 05Oct 23, 12[A61K]
8026210 Exendins and exendin agonist analogs to regulate gastrointestinal motilityJan 14, 09Sep 27, 11[A61K]
7981861 Method of performing angioplasty with a GLP-1 moleculeJun 23, 10Jul 19, 11[A61K, A61P, C07K, A61M]
7928065 Methods of treatment using exendin peptides or GLP-1 peptidesOct 07, 08Apr 19, 11[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0225,485 Compositions and Methods for the Control, Prevention and Treatment of Obesity and Eating DisordersAbandonedSep 28, 12Aug 29, 13[A61K]
8501693 Use of exendins and exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogenExpiredAug 06, 07Aug 06, 13[A61K]
2012/0294,855 GLP-1 RECEPTOR AGONIST COMPOUNDS FOR OBSTRUCTIVE SLEEP APNEAAbandonedOct 28, 10Nov 22, 12[A61K, A61P]
2012/0231,022 GLP-1 RECEPTOR AGONIST COMPOUNDS FOR SLEEP ENHANCEMENTAbandonedMay 27, 10Sep 13, 12[A61K, A61P]
2010/0323,955 METHODS FOR TREATING OBESITY AND OBESITY RELATED DISEASES AND DISORDERSAbandonedNov 14, 07Dec 23, 10[A61K, A61P]
2010/0168,011 Pharmaceutical Formulations and Methods for Making the SameAbandonedDec 11, 07Jul 01, 10[A61K, A61P]
2010/0125,054 Amylin and Amylin Agonists for Treating Psychiatric Diseases and DisordersAbandonedDec 18, 09May 20, 10[A61K, A61P]
7718400 Methods of increasing lean tissue mass using OB protein compositionsExpiredMar 16, 07May 18, 10[C07H, C12P, C12N, C07K]
2010/0009,907 Glucagon-Like Peptides and Uses ThereofAbandonedJul 06, 07Jan 14, 10[C07H, A61K, A61P, C07K]
2010/0004,166 Endothelin and Endothelin Receptor Agonists in the Treatment of Metabolic DiseasesAbandonedMar 23, 07Jan 07, 10[A61K, A61P]
2009/0239,796 METHODS FOR TREATING DIABETES AND REDUCING BODY WEIGHTAbandonedAug 18, 06Sep 24, 09[A61K, A61P]
2009/0209,469 Use of Exendins and GLP-1 Receptor Agonists for Altering Lipoprotein Particle Size and Subclass CompositionAbandonedAug 06, 07Aug 20, 09[A61K, A61P]
2009/0203,603 Compositions for the Treatment and Prevention of NephropathyAbandonedDec 18, 08Aug 13, 09[A61K]
2009/0186,817 PEPTIDE-PEPTIDASE INHIBITOR CONJUGATES AND METHODS OF USING SAMEAbandonedMar 21, 07Jul 23, 09[A61K, C07K]
7538182 Polypeptide and protein derivatives and process for their preparationExpiredSep 08, 06May 26, 09[A61K, C07K]
2009/0073,506 METHOD OF SETTING SCANNER-CONTROLLING INPUT SIGNAL AND DISPLAY APPARATUS APPLIED WITH THE SAMEAbandonedMar 25, 08Mar 19, 09[H04N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.